Scarica l'app Stockscreener
139.34
3.82%
-5.54
Dopo l'orario di chiusura:
139.09
-0.25
-0.18%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RGEN Giù?
Forum
Previsione
Precedente Chiudi:
$144.88
Aprire:
$140.65
Volume 24 ore:
443.63K
Relative Volume:
0.76
Capitalizzazione di mercato:
$8.13B
Reddito:
$633.51M
Utile/perdita netta:
$-8.10M
Rapporto P/E:
-449.48
EPS:
-0.31
Flusso di cassa netto:
$131.26M
1 W Prestazione:
-2.18%
1M Prestazione:
-14.34%
6M Prestazione:
-2.54%
1 anno Prestazione:
-29.17%
Intervallo 1D:
$137.92
$144.32
Intervallo di 1 settimana:
$137.92
$153.89
Portata 52W:
$113.50
$200.23
Repligen Corp Stock (RGEN) Company Profile
Nome
Repligen Corp
Settore
Industria
Telefono
(781) 449-9560
Indirizzo
41 SEYON STREET, WALTHAM, MA
Confronta RGEN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
139.34 | 8.13B | 633.51M | -8.10M | 131.26M | -0.31 |
|
ISRG
Intuitive Surgical Inc
|
491.81 | 176.29B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
231.85 | 66.57B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
91.37 | 45.19B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
221.11 | 32.48B | 4.93B | 1.25B | 1.38B | 8.47 |
|
BAX
Baxter International Inc
|
33.44 | 17.07B | 17.28B | 108.00M | 391.00M | 0.20 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-18 | Iniziato | Evercore ISI | In-line |
| 2025-02-10 | Iniziato | TD Cowen | Buy |
| 2024-12-17 | Iniziato | Canaccord Genuity | Hold |
| 2024-11-14 | Iniziato | Wolfe Research | Peer Perform |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-26 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-06-18 | Iniziato | Guggenheim | Neutral |
| 2023-12-04 | Downgrade | The Benchmark Company | Buy → Hold |
| 2023-07-20 | Iniziato | Wells Fargo | Overweight |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-03-28 | Iniziato | The Benchmark Company | Buy |
| 2022-12-14 | Iniziato | Deutsche Bank | Hold |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2021-10-14 | Iniziato | Exane BNP Paribas | Outperform |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-08-24 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-30 | Reiterato | H.C. Wainwright | Buy |
| 2020-05-07 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-23 | Reiterato | H.C. Wainwright | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-11-01 | Aggiornamento | First Analysis Sec | Outperform → Strong Buy |
| 2019-10-15 | Iniziato | SVB Leerink | Outperform |
| 2019-08-28 | Reiterato | First Analysis Sec | Outperform |
| 2019-08-23 | Ripresa | Stephens | Overweight |
| 2019-07-22 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2018-12-17 | Aggiornamento | CL King | Neutral → Buy |
| 2018-11-12 | Downgrade | CL King | Buy → Neutral |
| 2018-09-26 | Iniziato | H.C. Wainwright | Neutral |
| 2017-12-08 | Iniziato | Citigroup | Buy |
| 2017-12-05 | Iniziato | JP Morgan | Overweight |
| 2017-11-13 | Iniziato | CL King | Buy |
| 2017-10-02 | Aggiornamento | First Analysis Sec | Equal-Weight → Overweight |
| 2017-07-21 | Iniziato | William Blair | Outperform |
| 2017-02-13 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
Mostra tutto
Repligen Corp Borsa (RGEN) Ultime notizie
PNC Financial Services Group Inc. Sells 262 Shares of Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen Corp director Hunt Anthony sells $4.08 million in stock By Investing.com - Investing.com South Africa
Repligen Corp director Hunt Anthony sells $4.08 million in stock - Investing.com
Repligen’s SWOT analysis: bioprocessing leader’s stock faces growth and valuation challenges - Investing.com
Repligen (NASDAQ:RGEN) Coverage Initiated by Analysts at Evercore ISI - Defense World
Repligen Co. (NASDAQ:RGEN) Shares Sold by Victory Capital Management Inc. - Defense World
Repligen director Pax Margaret acquires $37,672 in common stock By Investing.com - Investing.com Australia
REPLIGEN Director Margaret Pax Acquires 250 Shares - TradingView
Evercore ISI sets Repligen stock In Line with $155 price target - Investing.com
Demystifying Repligen: Insights From 6 Analyst Reviews - Benzinga
Repligen initiated with an In Line at Evercore ISI - TipRanks
Repligen Corp (RGEN) Shares Up 5.72% on Mar 17 - GuruFocus.com
Repligen Corp (RGEN) Shares Up 5.72% on Mar 15 - GuruFocus.com
REPLIGEN CORP SEC 10-K Report - TradingView
William Blair Brokers Reduce Earnings Estimates for Repligen - Defense World
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack - The Globe and Mail
Oppenheimer & Co. Inc. Purchases New Shares in Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen Corporation’s Acquisition of Bioprocessing PAT Device Portfolio from 908 Devices - Global Legal Chronicle
US Bancorp DE Raises Position in Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen buying 908 Devices’ Bioprocess Analytics portfolio - BioWorld Online
Sanctuary Advisors LLC Sells 268 Shares of Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen (NASDAQ:RGEN) and Compass Therapeutics (NASDAQ:CMPX) Critical Review - Defense World
Truist Financial Corp Trims Stock Position in Repligen Co. (NASDAQ:RGEN) - Defense World
908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth - AOL
Leerink maintains Repligen stock Outperform rating, $200 target - Investing.com
908 Devices stock jumps on Repligen deal (RGEN:NASDAQ) - Seeking Alpha
Repligen acquires 908 Devices’ desktop bioprocessing tech - Investing.com
Repligen acquires 908 Devices’ desktop bioprocessing tech By Investing.com - Investing.com Canada
Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices - Yahoo Finance
Repligen Co. (NASDAQ:RGEN) Receives Consensus Rating of “Moderate Buy” from Brokerages - Armenian Reporter
Repligen Co. (NASDAQ:RGEN) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Global Retirement Partners LLC Has $53,000 Stock Position in Repligen Co. (NASDAQ:RGEN) - Defense World
Global Hollow Fiber Filtration Market: A Comprehensive Study - openPR
CIBC Asset Management Inc Acquires 81 Shares of Repligen Co. (NASDAQ:RGEN) - Defense World
Principal Financial Group Inc. Decreases Position in Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen’s SWOT analysis: bioprocessing leader’s stock poised for growth - Investing.com
Repligen stock holds steady after Benchmark maintains rating - Investing.com
Repligen stock holds steady after Benchmark maintains rating By Investing.com - Investing.com UK
Repligen (NASDAQ:RGEN) Price Target Raised to $200.00 - Defense World
Repligen (NASDAQ:RGEN) Price Target Raised to $205.00 - Armenian Reporter
Repligen (NASDAQ:RGEN) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - Defense World
Repligen (NASDAQ:RGEN) Earns Buy Rating from HC Wainwright - Defense World
Repligen (NASDAQ:RGEN) Shares Up 8.1% Following Strong Earnings - Defense World
Repligen Earnings: Encouraging Guidance Supports Attractive Growth Story - Morningstar
Repligen Offers Differentiated Solutions as a Leading Bioprocessing Supplier - Morningstar
Repligen (RGEN) Beats Q4 Earnings Estimates - MSN
Repligen's Q4 Earnings Beat Estimates, Revenues In Line - Yahoo Finance
The Analyst Verdict: Repligen In The Eyes Of 4 Experts - Benzinga
H.C. Wainwright maintains Buy on Repligen, target at $180 - Investing.com
Repligen Corporation (NASDAQ:RGEN) Q4 2024 Earnings Call Transcript - Insider Monkey
Canaccord raises Repligen stock target to $170, maintains Hold - Investing.com
Repligen Corp Azioni (RGEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.34%
1.61%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):